Last $11.20 USD
Change Today +0.3101 / 2.85%
Volume 406.0K
VNDA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:50 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - vanda pharmaceuticals inc (VNDA)

Name (Connections)Board RelationshipsTitleKey Developments
Richard Dugan 13 RelationshipsDirector and Chairman of Audit Committee 
Vincent Milano 160 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee 
Michael Cola 75 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - vanda pharmaceuticals inc (VNDA)

Name (Connections)Board RelationshipsTitle
Vincent Milano 160 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Howard Pien 57 RelationshipsDirector, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
H. Watkins 120 RelationshipsChairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
VNDA Compensation vs. Industry
515.0K
320.4K
Chief Executive Officer
315.0K
234.0K
Chief Financial Officer
Share price activity for VANDA PHARMACEUTICALS INC (VNDA)
52 Week Price Performance
VNDA
Industry Average

Nominating Committee* - vanda pharmaceuticals inc (VNDA)

Name (Connections)Board RelationshipsTitleKey Developments
H. Watkins 120 RelationshipsChairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation CommitteeVanda Pharmaceuticals, Inc. Announces Termination of Robert Repella, Senior Vice President and Chief Commercial Officer, Effective as of January 1, 2014
12/4/13
Howard Pien 57 RelationshipsDirector, Member of Nominating/Corporate Governance Committee and Member of Compensation CommitteeVanda Pharmaceuticals, Inc. Appoints Paolo Baroldi as Senior Vice President and Chief Medical Officer
04/17/13
Steven Galson M.D., M.P.H 6 RelationshipsDirector and Member of Nominating/Corporate Governance CommitteeVanda Pharmaceuticals, Inc. Announces Board and Committee Changes
06/18/12

Corporate Governance Committee* - vanda pharmaceuticals inc (VNDA)

Name (Connections)Board RelationshipsTitle
Steven Galson M.D., M.P.H 6 RelationshipsDirector, Chairman of Compensation Committee and Member of Audit Committee
Howard Pien 57 RelationshipsDirector, Member of Nominating/Corporate Governance Committee and Member of Compensation Committee
H. Watkins 120 RelationshipsChairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
VNDA and Competitor
Insiders vs. External
Board
29%
71%
Vanda Pharmaceuticals, Inc.
7%
93%
Pfizer Inc.
13%
87%
Eli Lilly and Company
14%
86%
AstraZeneca PLC
6%
94%
Sanofi
46%
54%
Sumitomo Dainippon Pharma Co., Ltd.
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VNDA:US $11.20 USD +0.3101

VNDA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,449 GBp -26.50
Eli Lilly & Co $70.68 USD -0.44
Pfizer Inc $34.67 USD -0.1047
Sanofi €86.51 EUR +0.11
Sumitomo Dainippon Pharma Co Ltd ¥1,305 JPY -15.00
View Industry Companies
 

Industry Analysis

VNDA

Industry Average

Valuation VNDA Industry Range
Price/Earnings 19.6x
Price/Sales 8.1x
Price/Book 2.5x
Price/Cash Flow 19.0x
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VANDA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.